Nice’s decision to deny NHS coverage for Lecanemab contrasts with MHRA’s approval, citing high costs and minimal benefits compared to risks of serious side-effects
As new research fuels the ongoing discussion on the best diet for health and weight loss, experts weigh in on the benefits and risks of low-carb and low-fat approaches